Cigna Group’s stock has delivered a 94% total return over five years, thanks to dividends doing the heavy lifting. Although ...

Marsh & McLennan reported a Q1 revenue of $7.06 billion, climbing 9.1% year-over-year but still slipping just below analyst ...

CVS Health got a Wall Street-style vitamin boost as Robert W. Baird upped its price target from $51 to $71, signaling ...

Boston Scientific isn’t just playing doctor—it’s operating with precision when it comes to earnings. The company has ...

Gabelli Funds put Mondelez International on a slight diet, shedding 34,000 shares but still nibbling on a hefty 753,150-share ...

Southwest Airlines plans to unveil its first-quarter 2025 financial results on April 24, 2025, via a live webcast. Key ...

As Trump’s tariffs threaten to inflate import prices, Etsy is steering shoppers toward homegrown treasures. Etsy CEO Josh ...

Rockefeller Capital Management slashed its PayPal stake by over 25%, unloading 191,073 shares and ending with just over $48 ...

Distillate Capital Partners made a splashy $26.6 million move into Lockheed Martin, snapping up 54,730 shares in Q4. Lockheed ...

Goldman Sachs dialed down its price target on Regeneron Pharmaceuticals, slicing it from $1,019 to $917, while still ...

Bristol Myers Squibb's stock dipped 1.35% to $49.33, outpacing the broader market’s even grimmer mood. The biopharma giant ...

Keystone Financial Group took a major leap in its NIKE investment game, increasing its stake by 271.4% in Q4. This dramatic ...